Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy

This study has been terminated.
(Adverse Events)
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
University of Southern California
ClinicalTrials.gov Identifier:
NCT01238965
First received: November 3, 2010
Last updated: September 9, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)